DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $765,000 | -48.7% | 56,827 | -26.1% | 0.02% | -39.3% |
| Q3 2018 | $1,492,000 | -20.2% | 76,874 | +5.2% | 0.03% | -39.1% |
| Q2 2018 | $1,869,000 | +16.9% | 73,074 | -8.0% | 0.05% | +21.1% |
| Q1 2018 | $1,599,000 | +33.7% | 79,393 | +33.1% | 0.04% | +22.6% |
| Q4 2017 | $1,196,000 | -9.2% | 59,661 | -6.2% | 0.03% | -3.1% |
| Q3 2017 | $1,317,000 | +41.0% | 63,589 | +0.8% | 0.03% | +33.3% |
| Q2 2017 | $934,000 | +926.4% | 63,072 | +1014.1% | 0.02% | +1100.0% |
| Q1 2017 | $91,000 | +31.9% | 5,661 | +3.2% | 0.00% | 0.0% |
| Q4 2016 | $69,000 | -54.9% | 5,486 | 0.0% | 0.00% | -71.4% |
| Q3 2016 | $153,000 | -5.0% | 5,486 | +19.2% | 0.01% | -12.5% |
| Q2 2016 | $161,000 | – | 4,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |